Inventor
ASOKAN ARAVIND
US23 patents
⚠️ This page may combine multiple inventors who share the name “ASOKAN ARAVIND”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV NORTH CAROLINA CHAPEL HILL
12 patentsUS9475845B2Oct 25, 2016
Modified virus vectors and methods of making and using the same
UNIV NORTH CAROLINA CHAPEL HILL76 citations98
US10077291B2Sep 18, 2018
Methods and compositions for dual glycan binding AAV vectors
UNIV NORTH CAROLINA CHAPEL HILL15 citations89
US11208438B2Dec 28, 2021
Methods and compositions for antibody-evading virus vectors
UNIV NORTH CAROLINA CHAPEL HILL5 citations80
US10745447B2Aug 18, 2020
Methods and compositions for antibody-evading virus vectors
UNIV NORTH CAROLINA CHAPEL HILL8 citations80
US10907176B2Feb 2, 2021
Methods and compositions for targeted gene transfer
UNIV NORTH CAROLINA CHAPEL HILL8 citations79
US11840555B2Dec 12, 2023
Methods and compositions for antibody-evading virus vectors
UNIV NORTH CAROLINA CHAPEL HILL1 citations69
US11718862B2Aug 8, 2023
Methods and compositions for circular RNA molecules
UNIV NORTH CAROLINA CHAPEL HILL2 citations62
US12466860B2Nov 11, 2025
Methods for using dual glycan binding AAV vectors
UNIV NORTH CAROLINA CHAPEL HILL0 citations59
US12049478B2Jul 30, 2024
Methods and compositions for dual glycan binding AAV vectors
UNIV NORTH CAROLINA CHAPEL HILL0 citations59
US11059862B2Jul 13, 2021
Methods and compositions for dual glycan binding AAV vectors
UNIV NORTH CAROLINA CHAPEL HILL0 citations59
US12281320B2Apr 22, 2025
Methods and compositions for antibody-evading virus vectors
UNIV NORTH CAROLINA CHAPEL HILL0 citations56
US11905312B2Feb 20, 2024
Methods and compositions for gene transfer across the vasculature
UNIV NORTH CAROLINA CHAPEL HILL1 citations53
UNIV DUKE
6 patentsUS12037598B2Jul 16, 2024
Cross-species compatible adeno-associated virus compositions and methods of use thereof
UNIV DUKE1 citations67
US12508305B2Dec 30, 2025
Compositions and methods for treating and/or preventing glycogen storage disease type III
UNIV DUKE0 citations57
US12577586B2Mar 17, 2026
Cross-species compatible adeno-associated virus compositions and methods of use thereof
UNIV DUKE0 citations56
US12146151B2Nov 19, 2024
Cross-species compatible adeno-associated virus compositions and methods of use thereof
UNIV DUKE0 citations56
US12533397B2Jan 27, 2026
Methods of treating ATPase-mediated diseases with a nucleic acid encoding ATP1A3 and a neuron-specific promoter
UNIV DUKE0 citations51
US11717560B2Aug 8, 2023
Compositions comprising nucleic acid molecules and methods of treating ATPase-mediated diseases
UNIV DUKE1 citations51